Company Filing History:
Years Active: 2014
Title: Hyungwook Lim: Innovator in Immune Response Modulation
Introduction
Hyungwook Lim is a prominent inventor based in San Francisco, CA. He has made significant contributions to the field of immunology, particularly through his innovative research and patent work. His expertise lies in the modulation of immune responses, which has important implications for treating various immune-related conditions.
Latest Patents
Hyungwook Lim holds a patent titled "Use of SIRT1 activators or inhibitors to modulate an immune response." This patent outlines methods for increasing or reducing immune responses in individuals. Specifically, it describes administering an inhibitor of SIRT1 to enhance immune responses and an activator of SIRT1 to treat chronic immune hyperactivity. The patent also details methods for modulating the activation and differentiation of CD4T cells, which are crucial for immune function.
Career Highlights
Hyungwook Lim is affiliated with the J. David Gladstone Institutes, where he conducts his research. His work has garnered attention for its potential to influence therapeutic strategies in immunology. Lim's innovative approaches have positioned him as a key figure in the ongoing exploration of immune response modulation.
Collaborations
Hyungwook Lim collaborates with notable colleagues, including Eric M. Verdin and Melanie Ott. These partnerships enhance the research environment and contribute to the advancement of knowledge in the field of immunology.
Conclusion
Hyungwook Lim's contributions to the field of immunology through his patent and research at the J. David Gladstone Institutes highlight his role as an influential inventor. His work on SIRT1 activators and inhibitors represents a significant advancement in understanding and modulating immune responses.